Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
955
mi
from 43215
Boca Raton, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
943
mi
from 43215
Boynton Beach, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
943
mi
from 43215
Boynton Beach, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
809
mi
from 43215
Celebration, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
809
mi
from 43215
Celebration, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
993
mi
from 43215
Miami, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
888
mi
from 43215
Port Saint Lucie, FL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
888
mi
from 43215
Port Saint Lucie, FL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
565
mi
from 43215
Des Moines, IA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
565
mi
from 43215
Des Moines, IA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
620
mi
from 43215
Kansas City, KA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
620
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
188
mi
from 43215
Louisville, KY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
177
mi
from 43215
Novi, MI
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
177
mi
from 43215
Novi, MI
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
499
mi
from 43215
Columbia, MO
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
499
mi
from 43215
Columbia, MO
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
609
mi
from 43215
Lebanon, NH
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
609
mi
from 43215
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
359
mi
from 43215
Charlotte, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
359
mi
from 43215
Charlotte, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
494
mi
from 43215
New Hyde Park, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
494
mi
from 43215
New Hyde Park, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
482
mi
from 43215
New Windsor, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
482
mi
from 43215
New Windsor, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
481
mi
from 43215
New York, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
492
mi
from 43215
White Plains, NY
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
492
mi
from 43215
White Plains, NY
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
357
mi
from 43215
Matthews, NC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
357
mi
from 43215
Matthews, NC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
408
mi
from 43215
Havertown, PA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
408
mi
from 43215
Havertown, PA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
416
mi
from 43215
Lugoff, SC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
416
mi
from 43215
Lugoff, SC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
463
mi
from 43215
Orangeburg, SC
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
463
mi
from 43215
Orangeburg, SC
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
1134
mi
from 43215
Fort Sam Houston, TX
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
1134
mi
from 43215
Fort Sam Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
1487
mi
from 43215
Saint George, UT
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
1487
mi
from 43215
Saint George, UT
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
Clinical Research Facility
2012
mi
from 43215
Tacoma, WA
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
Clinical Research Facility
2012
mi
from 43215
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated:  4/18/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Kelowna,
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment
Status: Enrolling
Updated: 4/18/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from 43215
Kelowna,
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
University of Alabama
492
mi
from 43215
Birmingham, AL
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
University of Alabama
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Childrens National Medical Center
328
mi
from 43215
Washington,
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Childrens National Medical Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Memorial Hospital, Chicago
276
mi
from 43215
Chicago, IL
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Memorial Hospital, Chicago
276
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Johns Hopkins Oncology Center
345
mi
from 43215
Baltimore, MD
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Johns Hopkins Oncology Center
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital/Dana Farber Cancer Institute
641
mi
from 43215
Boston, MA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital/Dana Farber Cancer Institute
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
St. Louis Children's Hospital
397
mi
from 43215
Saint Louis, MO
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
St. Louis Children's Hospital
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Beth Israel Med Ctr
478
mi
from 43215
New York, NY
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Beth Israel Med Ctr
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
SUNY Upstate Medical University
414
mi
from 43215
Syracuse, NY
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
SUNY Upstate Medical University
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Oregon Health and Sciences University
2026
mi
from 43215
Portland, OR
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Oregon Health and Sciences University
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Children's Hospital of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Children's Hospital of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated:  4/19/2018
Texas Children's Hospital
995
mi
from 43215
Houston, TX
Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status: Enrolling
Updated: 4/19/2018
Texas Children's Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Status: Enrolling
Updated:  4/19/2018
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
Status: Enrolling
Updated: 4/19/2018
University of Kansas Medical Center
627
mi
from 43215
Kansas City, KA
Click here to add this to my saved trials
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Phase I/II Trial of VELCADE® (Bortezomib) in Combination With Mitoxantrone and Etoposide for Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated:  4/23/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
416
mi
from 43215
Philadelphia, PA
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
Phase I/II Trial of VELCADE® (Bortezomib) in Combination With Mitoxantrone and Etoposide for Relapsed or Refractory Acute Leukemias
Status: Enrolling
Updated: 4/23/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Status: Enrolling
Updated:  4/24/2018
VA Portland Health Care System, Portland, OR
2027
mi
from 43215
Portland, OR
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Spectral Dynamics and Speech Understanding by Hearing Impaired People
Status: Enrolling
Updated: 4/24/2018
VA Portland Health Care System, Portland, OR
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials